Foundation Event

Dry AMD Webinar

Thursday, January 11th, 2024, 4:00 p.m. – 5:00 p.m. (EST)

The purpose of this webinar is to provide details about an upcoming Externally-Led Patient Focused Drug Development (EL-PFDD) meeting for dry AMD, and to provide background information about the Food and Drug Administration’s (FDA) drug review process.
Get updates on Foundation Event

Location

Virtual Event via Zoom

Columbia, MD 21045

RSVP

Join Live

The EL-PFDD meeting will be held virtually on March 1st, 2024, from 10:00 a.m. to 3:00 p.m. Eastern Time. The goal of the March 1st meeting is to educate FDA staff and other key stakeholders such as biotech and pharmaceutical companies about what it is like to live with dry AMD, with perspectives from both affected individuals as well as caregivers and family members of affected individuals. The FDA staff can use this information when reviewing new clinical trials or new drug applications for dry AMD. 
 
EL-PFDD meetings are unique among public meetings with the FDA and other stakeholders, with a format designed to engage patients and elicit their perspectives on two topic areas:

  1. Tthe most significant symptoms of their condition and the impact of the condition on daily life; and
  2. Current approaches to management or treatment.

Please join us on January 11 to learn about this important meeting for our community and how you can be involved. Your input is critical for ensuring that this meeting is successful, and we would appreciate as many people in attendance as possible.

We look forward to meeting with you!